Volume 9 - Issue 2 - February 2012
Case Report and Brief Review »
Persistent Hypotension After Carotid Artery Stenting
Madjid Chinikar, MD and Samira Arami, MD
Abstract
Carotid artery stenting (CAS) is the treatment of choice in high-risk patients with extracranial carotid occlusive disease.1 Bradycardia and hypotension are well-recognized complications of this procedure and are often transient and self-limiting.
Clinical Review »
Stenting for Use in the Treatment of Aortoiliac Occlusive Disease
Sean P. Lyden, MD
Abstract
Aortoiliac stenting is the treatment of choice for aortoiliac occlusive disease. After reviewing treatment techniques, research shows that outcomes are similar for balloon expandable and self-expanding stents. Covered stents are now being studied but no published benefit exists over uncovered stenting. Secondary patency of aortoiliac intervention rivals open surgery through 3 years.
Case Files by Dr. George »
Successful Endovascular Treatment of Common Femoral Artery Thrombosis Occurring 2 Months After Catheterization and Angioseal Closure
Troy Trayer, DO and Jon C. George, MD
Abstract
A patient presented for coronary angiography and followed by ad hoc percutaneous coronary intervention. Upon completion of the procedure, angiogram of the left common femoral artery revealed minimal disease, and an Angioseal vascular closure device was successfully deployed for hemostasis.
Interview »
Dr. David Rosenthal Speaks with VDM at the VEITH Symposium About Bioconvertible IVC Filters for the Prevention of Pulmonary Embolism
Interview by Amanda Wright
Why did you first think that a permanent bioconvertible IVC filter was the answer for patients with pulmonary embolism?
Vena caval filters came about in the early 1970s to prevent pulmonary embolisms. In the 1990s, they developed retrievable filters, but this involved its own risks and costs so we thought that a bioconvertible filter was best for protection during the high-risk period against pulmonary embolism.
